Evelo Biosciences, Inc. (EVLO)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
As of 01:50PM EDT. Market open.
| Previous close | 0.0505 |
| Open | 0.0600 |
| Bid | 0.0000 x 2900 |
| Ask | 0.0000 x 1000 |
| Day's range | 0.0450 - 0.0600 |
| 52-week range | 0.0280 - 13.9300 |
| Volume | |
| Avg. volume | 32,398 |
| Market cap | 854,226 |
| Beta (5Y monthly) | 1.95 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -15.6400 |
| Earnings date | 15 May 2024 - 20 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Insider MonkeyHorizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript
Horizon Technology Finance Corporation (NASDAQ:HRZN) Q3 2023 Earnings Call Transcript November 1, 2023 Operator: Greetings, and welcome to Horizon Technology Finance Corporation Third Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being […]
- Thomson Reuters StreetEvents
Q3 2023 Horizon Technology Finance Corp Earnings Call
Q3 2023 Horizon Technology Finance Corp Earnings Call
ZacksEvelo (EVLO) Drops 59% on Flunking Psoriasis Drug Study
Evelo's (EVLO) EDP2939 fails to achieve the primary endpoint in a mid-stage for treating moderate psoriasis. The company decides to cease clinical development on the candidate.
© 2024 Yahoo. All rights reserved.